Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tuberculosis | 8 | 2021 | 2895 | 1.06 | Why? |
| Sleep Apnea, Obstructive | 2 | 2019 | 668 | 0.85 | Why? |
| Tuberculosis, Pulmonary | 5 | 2020 | 1171 | 0.74 | Why? |
| Antitubercular Agents | 9 | 2020 | 775 | 0.68 | Why? |
| Exercise Tolerance | 1 | 2021 | 634 | 0.61 | Why? |
| Bronchiectasis | 1 | 2019 | 312 | 0.57 | Why? |
| Respiratory Tract Diseases | 1 | 2018 | 1061 | 0.41 | Why? |
| Tuberculosis, Multidrug-Resistant | 4 | 2019 | 433 | 0.40 | Why? |
| Nitroimidazoles | 3 | 2018 | 69 | 0.40 | Why? |
| Continuous Positive Airway Pressure | 1 | 2019 | 1187 | 0.40 | Why? |
| Oxazoles | 3 | 2018 | 75 | 0.40 | Why? |
| Diarylquinolines | 3 | 2018 | 90 | 0.39 | Why? |
| Patient Compliance | 1 | 2019 | 1468 | 0.37 | Why? |
| Respiratory Therapy | 3 | 2021 | 918 | 0.36 | Why? |
| Asthma | 3 | 2020 | 4383 | 0.31 | Why? |
| Quality of Life | 3 | 2021 | 9820 | 0.28 | Why? |
| Coinfection | 3 | 2021 | 6820 | 0.27 | Why? |
| Disease Eradication | 2 | 2018 | 581 | 0.22 | Why? |
| Extensively Drug-Resistant Tuberculosis | 2 | 2018 | 87 | 0.21 | Why? |
| Relaxation Therapy | 1 | 2019 | 112 | 0.19 | Why? |
| Patient Dropouts | 1 | 2019 | 96 | 0.19 | Why? |
| Exercise Test | 2 | 2021 | 911 | 0.17 | Why? |
| Tuberculosis Vaccines | 1 | 2018 | 89 | 0.17 | Why? |
| Walk Test | 1 | 2019 | 461 | 0.16 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.15 | Why? |
| Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 3832 | 0.15 | Why? |
| Respiration | 1 | 2021 | 729 | 0.15 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.15 | Why? |
| European Union | 1 | 2019 | 565 | 0.14 | Why? |
| Rehabilitation | 1 | 2018 | 386 | 0.12 | Why? |
| Respiratory Function Tests | 1 | 2019 | 1755 | 0.12 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.11 | Why? |
| Eosinophils | 1 | 2017 | 848 | 0.11 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.10 | Why? |
| Patient Education as Topic | 1 | 2019 | 1476 | 0.10 | Why? |
| Sputum | 1 | 2017 | 1720 | 0.10 | Why? |
| Humans | 30 | 2021 | 930598 | 0.09 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.09 | Why? |
| Severity of Illness Index | 7 | 2020 | 48226 | 0.09 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2014 | 595 | 0.09 | Why? |
| Transients and Migrants | 1 | 2020 | 1468 | 0.09 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.08 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.08 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.08 | Why? |
| Coronary Artery Disease | 1 | 2021 | 2570 | 0.08 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.08 | Why? |
| Noninvasive Ventilation | 2 | 2020 | 2329 | 0.08 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.08 | Why? |
| Socioeconomic Factors | 2 | 2021 | 8495 | 0.08 | Why? |
| Body Mass Index | 1 | 2019 | 4306 | 0.07 | Why? |
| Patient Care Team | 1 | 2019 | 3556 | 0.07 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.07 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
| Global Health | 2 | 2018 | 13911 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.06 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.06 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.06 | Why? |
| Pulmonary Medicine | 2 | 2018 | 706 | 0.05 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.05 | Why? |
| Exercise Therapy | 2 | 2021 | 976 | 0.05 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.05 | Why? |
| Heart Failure | 1 | 2021 | 6638 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Aged | 7 | 2021 | 215776 | 0.05 | Why? |
| Vital Signs | 1 | 2021 | 257 | 0.05 | Why? |
| Drug Repositioning | 1 | 2018 | 5683 | 0.05 | Why? |
| Directly Observed Therapy | 1 | 2018 | 34 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Length of Stay | 3 | 2021 | 11042 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Male | 10 | 2021 | 367725 | 0.04 | Why? |
| Female | 10 | 2021 | 380317 | 0.04 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.04 | Why? |
| Lung | 3 | 2020 | 31049 | 0.04 | Why? |
| Masks | 1 | 2019 | 8528 | 0.04 | Why? |
| Bacteriological Techniques | 1 | 2018 | 239 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Italy | 4 | 2021 | 38444 | 0.04 | Why? |
| Cryptogenic Organizing Pneumonia | 1 | 2014 | 35 | 0.04 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.03 | Why? |
| Partial Pressure | 1 | 2014 | 279 | 0.03 | Why? |
| Respiratory Insufficiency | 1 | 2014 | 7301 | 0.03 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.03 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.03 | Why? |
| Pulmonary Gas Exchange | 1 | 2014 | 414 | 0.03 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.03 | Why? |
| Emigrants and Immigrants | 1 | 2020 | 888 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| BCG Vaccine | 1 | 2020 | 1137 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2018 | 1425 | 0.03 | Why? |
| Disabled Persons | 1 | 2021 | 1152 | 0.03 | Why? |
| Blood Pressure | 1 | 2021 | 2198 | 0.02 | Why? |
| Mexico | 1 | 2018 | 2787 | 0.02 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Epidemics | 2 | 2020 | 6407 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.02 | Why? |
| Radiography | 1 | 2014 | 1576 | 0.02 | Why? |
| Clinical Protocols | 1 | 2018 | 2734 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Delivery of Health Care, Integrated | 1 | 2018 | 1549 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.02 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.02 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.02 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Health Status | 1 | 2018 | 3259 | 0.02 | Why? |
| Acute Disease | 1 | 2014 | 6029 | 0.01 | Why? |
| Adult | 4 | 2020 | 244371 | 0.01 | Why? |
| Oxygen | 1 | 2014 | 3715 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.01 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.01 | Why? |
| Critical Care | 1 | 2019 | 14081 | 0.01 | Why? |
| Pneumonia | 1 | 2014 | 5652 | 0.01 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2018 | 10697 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
Visca's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(171)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_